The Middle East and Africa medical devices market size was valued at USD 23.41 billion in 2024 and is projected to grow from USD 24.61 billion in 2025 to USD 34.95 billion by 2032, at a steady CAGR of 5.1% during the forecast period. This growth is driven by rising patient volumes at healthcare facilities, government backing for local manufacturing, and converging medical device regulations across the region.
Key Market Drivers
Hospital Expansion & Growing Patient Pool The region's rapidly expanding population and evolving healthcare demands are fueling infrastructure development. Countries like the UAE are positioning themselves as global healthcare manufacturing hubs — notably through the UAE government's Operation 300bn initiative, which encourages industrial growth and local production in the healthcare sector. The UAE also ranked 20th best healthcare country globally in the 2021 World Index of Healthcare Innovation, reflecting the region's upward trajectory.
Government Support & Local Manufacturing Government-led initiatives are accelerating market growth. In October 2022, the Ministry of Industry and Advanced Technology (MoIAT) signed MoUs worth USD 70.8 million with companies including PureHealth, Julphar, and Borouge to manufacture medical equipment locally and boost the UAE's export competitiveness.
Get a Free Sample PDF - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/middle-east-and-africa-medical-devices-market-107573
Restraints & Challenges
Despite strong momentum, the market faces headwinds. Regulatory bodies such as SAHPRA in South Africa and MOHAP in the UAE have structured but complex approval processes — lengthy timelines and documentation requirements create barriers for new product launches. Frequent policy updates also compel companies to continuously adapt their clinical study processes, causing delays.
Additionally, poor healthcare infrastructure in many sub-Saharan and developing nations limits penetration of technologically advanced medical devices, creating a significant disparity between GCC countries and the broader Africa region.
Market Opportunities & Trends
Clinical Trials & Innovation Market players are increasingly conducting clinical studies in the region. In June 2024, AbbVie initiated a clinical trial across Saudi Arabia and South Africa, generating awareness and demand for advanced devices.
Strategic Partnerships Major players are leveraging collaborations to strengthen their regional presence. In March 2025, Medtronic partnered with Methinks AI to enhance stroke treatment across Africa and the Middle East. In October 2024, Olympus Corporation partnered with Proximie to digitize operating rooms across EMEA.
Wearable & Home Care Devices Post-pandemic adoption of remote patient monitoring, wearable devices, and telehealth integration continues to rise, particularly for chronic disease management. Demand for monitoring and diagnostic imaging devices is growing due to the increasing prevalence of cardiac disorders.
Contract Manufacturing Growth Regional manufacturing hubs in UAE, Saudi Arabia, and Turkey are expanding. Smart manufacturing incorporating AI, IoT, and automation is enhancing scalability and quality compliance.
Segmentation Analysis
By Type In-vitro diagnostics (IVD) led the market in 2024, bolstered by expanding production capacities. For example, in January 2024, Codix Pharma Limited inaugurated its first IVD manufacturing facility in Lagos, Nigeria, targeting diabetes care in Africa. The dental segment is projected to grow at the fastest CAGR through 2032, driven by rising dental disorder burden and growing awareness of treatments like aligners.
By End User Hospitals & Ambulatory Surgical Centers (ASCs) dominated in 2024 and are expected to continue leading through the forecast period. Growing chronic disease burden, alongside public-private partnerships with hospitals, fuels this dominance. The clinics segment is also expected to grow significantly with the rise of private facilities and regional economic expansion.
Regional Outlook
GCC generated the highest market value at USD 10.71 billion in 2024, driven by high healthcare spending, rising chronic disease prevalence, and active medical conferences such as Arab Health — where companies like Koninklijke Philips N.V. showcased next-generation AI-enabled MRI, CT, and ultrasound systems in January 2025.
South Africa is set for significant growth, fueled by rising infectious disease prevalence and increasing demand for effective diagnostics. The rest of MEA is expected to expand substantially as awareness around diagnosis and treatment options grows.
Key Players
Leading companies in the MEA medical devices market include Koninklijke Philips N.V., GE HealthCare, Medtronic, Siemens Healthcare, F. Hoffmann-La Roche Ltd, Stryker, Johnson & Johnson, B. Braun SE, Getinge AB, and Drägerwerk AG. These companies are competing through product innovation, regional partnerships, and aggressive showcasing at healthcare conferences across the region.